Search
for
Sort by
Research 241–270 of 1000+
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- The connection of 5-alpha reductase inhibitors to the development of depression
- Desmodesmus pannonicus Water Extract Inhibits Melanin Synthesis and Promotes Wound Healing
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- Adenovirus-Mediated Wnt5a Expression Inhibits the Telogen-To-Anagen Transition of Hair Follicles in Mice
- Lambertianic Acid from Platycladus orientalis Inhibits Muscle Atrophy in Dexamethasone-Induced C2C12 Muscle Atrophy Cells
- N-(3,5-Dimethylphenyl)-3-Methoxybenzamide (A3B5) Targets TRP-2 and Inhibits Melanogenesis and Melanoma Growth
- Screening of Tyrosinase, Xanthine Oxidase, and α-Glucosidase Inhibitors from Polygoni Cuspidati Rhizoma et Radix by Ultrafiltration and HPLC Analysis
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Platycladus orientalis Leaf Extract Promotes Hair Growth via Non-Receptor Tyrosine Kinase ACK1 Activation
- Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Exosomal miR-222-3p derived from dermal papilla cells inhibits melanogenesis in melanocytes by targeting SOX10 in rabbits
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Deucravacitinib in dermatology: current indication and existing off-label data
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Review of Promising Off-Label Use of Deucravacitinib
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Inibidores das Janus Associated Kinases na Terapêutica Farmacológica
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- “PRIDE” Complex